Experts in Japan developed a mosquito that spreads vaccine rather than disease when it bites humans, it emerged March 19.

DNA

SAN DIEGO — Inovio Biomedical Corp. announced Feb. 23 that representatives and associates of the company will make multiple presentations at the DNA Vaccines 2010 conference March 2 through 4 in New Orleans.

Vical Inc. announced that it would present an overview of its DNA vaccine and adjuvant technologies and an update on its clinical-stage vaccine development programs at the Phacilitate Vaccine Forum in Washington.

National Institute of Allergy and Infectious Diseases

WASHINGTON — The National Institute of Allergy and Infectious Diseases has completed enrollment in a small clinical trial testing a candidate DNA vaccine for 2009 H1N1 influenza, the agency announced Dec. 11.

The H1N1 swine flu has sickened at least 22 million and killed almost 4,000 in the United States since April, according to the Centers for Disease Control and Prevention.

SAN DIEGO — Vical Inc. on Nov. 4 reported financial results for the quarter ended Sept. 30.

GALVESTON, Texas — Vical Inc. reported Nov. 10 that it has a strong rationale advocating the use of DNA vaccine technology for emerging and/or pandemic infectious diseases.